Back to Search
DR. JEFFREY B HAINSWORTH D.O.
D.O.
Neurology Physician
NPI: 1013295716IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
0102203438(VA)291171(MA)
Education
TOURO UN COL OF OSTEOPATHIC MEDICINE, NEW YORK
Class of 2011
Research & Publications (20)
Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
PMID 16729913·Clin Genitourin Cancer·2006
3-trial
Volunteers' experiences of becoming arthritis self-management lay leaders: "It's almost as if I've stopped aging and started to get younger!".
PMID 11501726·Arthritis Rheum·2001
8-other
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
PMID 19299236·Clin Breast Cancer·2009
3-trial
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck.
PMID 19288572·Cancer·2009
3-trial
Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
PMID 19525191·Clin Lymphoma Myeloma·2009
3-trial
Follicular lymphoma in the United States: first report of the national LymphoCare study.
PMID 19204203·J Clin Oncol·2009
8-other
A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib.
PMID 19272767·Eur J Cancer·2009
8-other
A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.
PMID 19433964·Am J Clin Oncol·2009
3-trial
Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.
PMID 19661042·Clin Breast Cancer·2009
3-trial
Treatment for patients with unknown primary cancer and favorable prognostic factors.
PMID 19179187·Semin Oncol·2009
6-review
Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.
PMID 19255328·J Clin Oncol·2009
3-trial
Final survival and safety results from a multicenter, open-label, phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer.
PMID 18438878·Cancer·2008
3-trial
Psychosocial characteristics of adults who experience difficulties with retching.
PMID 18513848·J Dent·2008
8-other
Evaluation of dentists' perceived needs regarding treatment of the anxious patient.
PMID 18425075·Br Dent J·2008
8-other
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
PMID 18189296·Cancer·2008
3-trial
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
PMID 18640933·J Clin Oncol·2008
4-observational
High-dose etoposide: from phase I to a component of curative therapy.
PMID 18838698·J Clin Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 736 CAMBRIDGE ST
BRIGHTON, MA 02135 - Phone
- (617) 789-2375
Quick Facts
- NPI
- 1013295716
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile